Polymorphisms in human DNA repair genes and head and neck squamous cell carcinoma

Journal of Genetics

Volumn 91, Issue 3, 2012, Pages 375-384

  Khlifi, Rim ^a,b   Rebai, Ahmed ^b   Hamza Chaffai, Amel ^a  

^a University of Sfax   (Tunisia)

^b CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

Author keywords

ERCC2 (XPD) gene; head and neck squamous cell carcinoma; XRCC1 gene; XRCC3 gene

Indexed keywords

EID: 84873119857     PISSN: 00221333     EISSN: 09737731     Source Type: Journal    
DOI: 10.1007/s12041-012-0193-z     Document Type: Article

References (83)

1. Affatato A. A., Wolfe K. J., Lopez M. S., Hallberg C., Ammenheuser M. M. and Abdel-Rahman S. Z. 2004 Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK. Environ. Mol. Mutagen. 44, 65-73.
2. Báez A. 2008 Genetic and environmental factors in head and neck cancer genesis. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 26, 174-200.
3. Benhamou S. and Sarasin A. 2005 ERCC2/XPD gene polymorphisms and lung cancer, a HuGE review. Am. J. Epidemiol. 161, 1-14.
4. Brennan P. and Boffetta P. 2004 Mechanistic considerations in the molecular epidemiology of head and neck cancer. IARC Sci. Publ. 157, 393-414.
5. Broughton B. C., Steingrimsdottir H. and Lehmann A. R. 1996 Five polymorphisms in the coding sequence of the xeroderma pigmentosum group D gene. Mutat. Res. 362, 209-211.
6. Butkiewicz D., Rusin M., Enewold L., Shields P. G., Chorazy M. and Harris C. C. 2001 Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis22, 593-597.
7. Canova C., Hashibe M., Simonato L., Nelis M., Metspalu A., Lagiou P. et al. 2009 Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries, The ARCAGE Project. Cancer Res. 69, 2956-2965.
8. Cao Y., Miao X. P., Huang M. Y., Deng L., Hu L. F., Ernberg I. et al. 2006 Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer6, 167.
9. Cao C., Zhang Y., Wang R., Sun S., Shen Z., Ma H. Y. et al. 2011 Excision repair cross complementation groups polymorphisms and lung cancer risk: a meta-analysis. Chin. Med. J. 124, 2203-2208.
10. Chen J. Y., Chen C. J., Liu M. Y., Cho S. M., Hsu M. M., Lynn T. C. et al. 1989 Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan. J. Med. Virol. 27, 269-273.
11. Cheng L., Eicher S. A., Guo Z., Hong W. K., Spitz M. R. and Wei Q. 1998 Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol. Biomarkers Prev. 7, 465-468.
12. Cho E. Y., Hildesheim A., Chen C. J., Hsu M. M., Chen I. H., Mittl B. F. et al. 2003 Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol. Biomarkers Prev. 12, 1100-1104.
13. Clarkson S. G. and Wood R. D. 2005 Polymorphisms in the human XPD (ERCC2) gene DNA repair capacity and cancer susceptibility, an appraisal. DNA Repair4, 1068-1074.
14. Coin F., Marinoni J. C., Rodolfo C., Fribourg S., Pedrini A. M. and Egly J. M. 1998 Mutations in the XPD helicase gene result in XP and TTD phenotypes preventing interaction between XPD and the p44 subunit of TFIIH. Nat. Genet. 20, 184-188.
15. Csejtei A., Tibold A., Koltai K., Varga Z., Szanyi I., Gobel G. et al. 2009 Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population. Anticancer Res. 29, 4169-4173.
16. Egly J. M. 2001 The 14th Datta Lecture TFIIH, from transcription to clinic. FEBS Lett. 498, 124-128.
17. Flores-Obando R. E., Gollin S. M. and Ragin C. C. 2010 Polymorphisms in DNA damage response genes and head and neck cancer risk. Biomarkers15, 379-399.
18. Frank S. A. 2004 Genetic variation in cancer predisposition, mutational decay of a robust genetic control network. Proc. Natl. Acad. Sci. USA101, 8061-8065.
19. Friedberg E. C. 2001 How nucleotide excision repair protects against cancer. Nat. Rev. Cancer1, 22-33.
20. Gal T. J., Huang W. Y., Chen C., Hayes R. B. and Schwartz S. M. 2005 DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients. Laryngoscope115, 2221-2231.
21. Gallegos-Hernández J. F. 2006 Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of head and neck mucosa. Cir. Cir. 74, 287-293 (in Spanish).
22. Garavello W., Foschi R., Talamini R., La Vecchia C., Rossi M., Dal Maso L. et al. 2008 Family history and the risk of oral and pharyngeal cancer. Int. J. Cancer122, 1827-1831.
23. Ginsberg G., Angle K., Guyton K. and Sonawane B. 2011 Polymorphism in the DNA repair enzyme XRCC1, Utility of current database and implications for human health risk assessment. Mutat. Res. 727, 1-15.
24. Gugatschka M., Dehchamani D., Wascher T. C., Friedrich G. and Renner W. 2011 DNA repair gene ERCC2 polymorphisms and risk of squamous cell carcinoma of the head and neck. Exp. Mol. Pathol. 91, 331-334.
25. Han S., Zhang H. T., Wang Z., Xie Y., Tang R., Mao Y. et al. 2006 DNA repair gene XRCC3 polymorphisms and cancer risk, a meta-analysis of 48 case-control studies. Eur. J. Hum. Genet. 14, 1136-1144.
26. Harth V., Schafer M., Abel J., Maintz L., Neuhaus T., Besuden M. et al. 2008 Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. J. Toxicol. Environ. Health A71, 887-897.
27. Hildesheim A. and Levin P. H. 1993 Etiology of nasopharyngeal carcinoma, a review. Epidemiol. Rev. 15, 466-485.
28. Hsieh L. L., Chien H. T., Chen I. H., Liao C. T., Wang H. M., Jung S. M. et al. 2003 The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas. Cancer Epidemiol. Biomarkers Prev. 12, 439-443.
29. Hu J. J., Mohrenweiser H. W., Bell D. A., Leadon S. A. and Miller M. S. 2002 Symposium overview, genetic polymorphisms in DNA repair and cancer risk. Toxicol. Appl. Pharm. 185, 64-73.
30. Huang C. W., Olshan A. F., Schwartz S. M., Berndt S. I., Chen C., Llaca V. et al. 2005 Selected genetic polymorphisms in MGMT XRCC1 XPD and XRCC3 and risk of head and neck cancer, a pooled analysis. Cancer Epidemiol. Biomarkers Prev. 14, 1747-1753.
31. Hung R. J., Hall J., Brennan P. and Boffetta P. 2005 Genetic polymorphisms in the base excision repair pathway and cancer risk, a HuGE review. Am. J. Epidemiol. 162, 925-942.
32. Ingelman-Sundberg M. 2001 Genetic variability in susceptibility and response to toxicants. Toxicol. Lett. 120, 259-268.
33. Jelonek K., Gdowicz-Klosok A., Pietrowska M., Borkowska M., Korfanty J., Rzeszowska-Wolny J. and Widlak P. 2010 Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon head and neck and breast cancers in a Polish population. J. Appl. Genet. 51, 343-352.
34. Kietthubthew S., Sriplung H., Au W. W. and Ishida T. 2006 Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int. J. Hyg. Environ. Health209, 21-29.
35. Knudson Jr A. G. 1989 The genetic predisposition to cancer. Birth Defects Orig. Artic. Ser. 25, 15-27.
36. Kotnis A., Sarin R. and Mulherkar R. 2005 Genotype, phenotype and cancer, role of low penetrance genes and environment in tumour susceptibility. J. Biosci. 30, 93-102.
37. Kowalski M., Przybylowska K., Rusin P., Olszewski J., Morawiec-Sztandera A., Bielecka-Kowalska A. et al. 2009 Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. J. Exp. Clin. Cancer Res. 28, 37.
38. Krupa R., Kasznicki J., Gajêcka M., Rydzanicz M., Kiwerska K., Kaczmarczyk D. et al. 2011 Polymorphisms of the DNA repair genes XRCC1 and ERCC4 are not associated with smoking-and drinking-dependent larynx cancer in a Polish population. Exp. Oncol. 33, 55-56.
39. Kumar A., Pant M. C., Singh H. S. and Khandelwal S. 2012 Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population. Mut. Res. 729, 24-34.
40. Laantri N., Jalbout M., Khyatti M., Ayoub W. B., Dahmoul S., Ayad M. et al. 2011 XRCC1 and hOGG1 genes and risk of nasopharyngeal carcinoma in North African countries. Mol. Carcinog. 50, 732-737.
41. Laczmanska I., Gil J., Karpinski P., Stembalska A., Kozlowska J., Busza H. et al. 2006 Influence of polymorphisms in xenobiotic-metabolizing genes and DNA-repair genes on diepoxybutane-induced SCE. Environ. Mol. Mutagen. 47, 666-673.
42. Li C., Hu Z., Lu J., Liu Z., Wang L. E., El-Naggar A. K. et al. 2007 Genetic polymorphisms in DNA base-excision repair genes ADPRT XRCC1 and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer110, 867-875.
43. Ma L., Hoeijmakers J. H. and Vander E. A. J. 1995 Mammalian nucleotide excision repair. Biochem. Biophys. Acta. 1242, 137-163.
44. Majumder M., Sikdar N., Paul R. R. and Roy B. 2005 Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes, one on each of two loci GSTM3 and XRCC1 (Codon 280). Cancer Epidemiol. Biomarkers Prev. 14, 2106-2112.
45. Majumder M., Sikdar N., Ghosh S. and Roy B. 2007 Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int. J. Cancer120, 2148-2156.
46. Mao L., Hong W. K. and Papadimitrakopoulou V. A. 2004 Focus on head and neck cancer. Cancer Cell5, 311-316.
47. Matullo G., Palli D., Peluso M., Guarrera S., Carturan S., Celentano E. et al. 2001 XRCC1., XRCC3., XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. Carcinogenesis22, 1437-1445.
48. Matullo G., Dunning A. M., Guarrera S., Baynes C., Polidoro S. et al. 2006 DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis27, 997-1007.
49. Mitra A. K., Singh N., Garg V. K., Chaturvedi R., Sharma M. and Rath S. K. 2009 Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to squamous cell carcinomas of the head and neck (SCCHN) and breast cancer in the north Indian population. J. Exp. Clin. Cancer Res. 28, 104.
50. Olshan A. F., Watson M. A., Weissler M. C. and Bell D. A. 2002 XRCC1 polymorphisms and head and neck cancer. Cancer Lett. 178, 181-186.
51. Pan Q. H., Cao Y., Xu J. F., Chen L. Z., Feng Q. S., Zeng Y. X. and Jia W. H. 2007 Family-based association study of XRCC1 gene polymorphisms in nasopharyngeal carcinoma. Chin. J. Med. Genet. 41, 12-16.
52. Parkin D. M., Muir C. S., Whelan S. L., Gao Y. T., Ferlay J. and Powell J. 1992 Cancer incidence in five continents, volume VI. IARC Science Publication No 120. Lyon, France.
53. Penel N., Amela E. Y., Mallet Y., Lefebvre D., Clisant S., Kara A. et al. 2007 A simple predictive model for postoperative mortality after head and neck cancer surgery with opening of mucosa. Oral Oncol. 43, 174-180.
54. Qiao Y., Spitz M. R., Shen H., Guo Z., Shete S., Hedayati M. et al. 2002 Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis23, 295-299.
55. Ramachandran S., Ramadas K., Hariharan R., Rejnish K. R. and Radhakrishna P. M. 2006 Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol. 42, 350-362.
56. Rybicki B. A., Conti D. V., Moreira A., Cicek M., Casey G. and Witte J. S. 2004 DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 13, 23-29.
57. Sancar A. 1995 Excision repair in mammalian cells. J. Biol. Chem. 270, 15915-15918.
58. Shen H., Sturgis E. M., Dahlstrom K. R., Zheng Y., Spitz Q. and Wei M. R. 2002 A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck, a case-control analysis. Int. J. Cancer99, 869-872.
59. Shen M. R., Jones I. M. and Mohrenweiser H. 1998 Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 58, 604-608.
60. Shields P. G. and Harris C. C. 1991 Molecular epidemiology and the genetics of environmental cancer. JAMA266, 681-687.
61. Sliwinski T., Walczak A., Przybylowska K., Rusin P., Pietruszewska W., Zielinska-Blizniewska H. et al. 2010 Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population. Exp. Mol. Pathol. 89, 358-366.
62. Spitz M. R., Wu X., Wang Y., Wang L. E., Shete S., Amos C. I. et al. 2001 Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 61, 1354-1357.
63. Stern M. C., Johnson L. R., Bell D. A. and Taylor J. A. 2002 XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 11, 1004-1011.
64. Sterpone S. and Cozzi R. 2010 Influence of XRCC1 genetic polymorphisms on ionizing radiation-induced DNA damage and repair. J. Nucleic Acids (doi: 10. 4061/2010/780369).
65. Sturgis E. M., Spitz M. R. and Wei Q. 1998 DNA repair and genomic instability in tobacco induced malignancies of the lung and upper aerodigestive tract. Environmental carcinogenesis and ecotoxicology reviews. J. Environ. Sci. Health Part C16, 1-30.
66. Sturgis E. M., Castillo E. J., Li L., Zheng R., Eicher S. A., Clayman G. L. et al. 1999 Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis20, 2125-2159.
67. Sturgis E. M., Zheng R., Li L., Castillo E. J., Eicher S. A., Chen M. et al. 2000 XPD/ERCC2 polymorphisms and risk of head and neck cancer, a case-control analysis. Carcinogenesis21, 2219-2223.
68. Sturgis E. M., Castillo E. J., Li L., Eicher S. A., Strom S. S., Spitz M. R. and Wei Q. 2002a XPD/ERCC2 EXON 8 Polymorphisms, rarity and lack of significance in risk of squamous cell carcinoma of the head and neck. Oral Oncol. 38, 475-477.
69. Sturgis E. M., Dahlstrom K. R., Spitz M. R. and Wei Q. 2002b DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg. 128, 1084-1088.
70. Sturgis E. M., Wei Q. and Spitz M. R. 2004 Descriptive epidemiology and risk factors for head and neck cancer. Semin. Oncol. 31, 726-733.
71. Tebbs R. S., Zhao Y., Tucker J. D., Scheerer J. B., Siciliano M. J., Hwang M. et al. 1995 Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc. Natl. Acad. Sci. USA92, 6348-6354.
72. Thompson L. H. and West M. G. 2000 XRCC keeps DNA from getting stranded. Mutat. Res. 459, 1-18.
73. Valko M., Rhodes C. J., Moncol J., Izakovic M. and Mazur M. 2006 Free radicals., metals 524 and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160, 1-40.
74. Vineis P., Alavanja M., Buffler P., Fontham E., Franceschi S., Gao Y. T. et al. 2004 Tobacco and cancer, recent epidemiological evidence. J. Natl. Cancer Inst. 96, 99-106.
75. Vispe S., Yung T. M., Ritchot J., Serizawa H. and Satoh M. S. A. 2000 Cellulardefense pathway regulating transcription through poly(ADP-ribosyl)ation in response to DNA damage. Proc. Natl. Acad. Sci. USA97, 9886-9891.
76. Viswanathan H. and Wilson J. A. 2004 Alcohol-the neglected factor in head and neck cancer. Clin. Otolaryngol. 29, 295-300.
77. Vogel U., Hedayati M., Dybdahl M., Grossman L. and Nexo B. A. 2001 Polymorphisms of the DNA repair gene XPD, correlations with risk of basal cell carcinoma revisited. Carcinogenesis22, 899-904.
78. Werbrouck J., Ruyck K. D., Duprez F., Eijkeren M. V., Rietzschel E., Bekaert S. et al. 2008 Single-nucleotide polymorphisms in DNA double-strand break repair genes, Association with head and neck cancer and interaction with tobacco use and alcohol consumption. Mutat. Res. 656, 74-81.
79. Yang H., Lippman S. M., Huang M., Lee J. J., Wang W., Spitz M. R. and Wu X. 2008 Genetic polymorphisms in double-strand break DNA repair genes associate with risk of oral premalignant lesions. Eur. J. Cancer44, 1603-1611.
80. Yang Y., Tian H. and Zhang Z. J. 2008 Association of the XRCC1 and hOGG1 polymorphisms with the risk of laryngeal carcinoma. Chin. J. Med. Genet. 25, 211-213.
81. Yuan J. M., Wang X. L., Xiang Y. B., Gao Y. T., Ross R. K. and Yu M. C. 2000a Non-dietary risk factors for nasopharyngeal carcinoma in Shanghai China. Int. J. Cancer85, 364-369.
82. Yuan J. M., Wang X. L., Xiang Y. B., Gao Y. T., Ross R. K. and Yu M. C. 2000b Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai China. Int. J. Cancer85, 358-363.
83. Zhou C., Zhou Y., Li J., Zhang Y., Jiang L., Zeng X. et al. 2009 The Arg149Trp polymorphism in the X-ray repair cross-complementing group 1 gene as a potential risk factor of oral cancer: a meta-analysis. Tohoku. J. Exp. Med. 219, 43-51.